THC

HighBridge Premium and Surly Brewing Announce Collaboration

Retrieved on: 
Thursday, March 28, 2024
Growth, Entrepreneurship, International, Energy drink, Drink, THC, Marketing

SHERIDAN, Wyo., March 28, 2024 /PRNewswire/ -- HighBridge Holdings, Inc. and Surly Brewing are pleased to announce they have entered into a contract for production of HighBridge Premium's THC infused beverages.

Key Points: 
  • SHERIDAN, Wyo., March 28, 2024 /PRNewswire/ -- HighBridge Holdings, Inc. and Surly Brewing are pleased to announce they have entered into a contract for production of HighBridge Premium's THC infused beverages.
  • "As we complete the renovation, Surly will be uniquely equipped to provide the efficiency, capacity and quality required by HighBridge.
  • We look forward to providing production services for HighBridge, a leading Multi-State Organization dedicated to premium quality infused beverages", said Tom Nientimp, Surly COO.
  • Its willingness to adapt to new ideas and products, and overall reputation for quality and state-of-the-art facilities, assures a solid collaboration between Surly and HighBridge.

MediPharm Labs Reports Fourth Quarter and Full Year Results

Retrieved on: 
Wednesday, March 27, 2024
OPEX, Brazilian Health Regulatory Agency, CFO, International, Webcast, Patient, VIVO, Research, Good manufacturing practice, Acquisition, Prescription, ANVISA, GMP, Adjustment, TSX, Cannabis, Good, THC, Marketing, Fine chemical

TORONTO, March 27, 2024 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, today announced its financial results for the full year and three months ended December 31, 2023.

Key Points: 
  • TORONTO, March 27, 2024 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, today announced its financial results for the full year and three months ended December 31, 2023.
  • MediPharm has two medical cannabis products with ANVISA authorizations and will increase deliveries to a new pharma partner in 2024.
  • David Pidduck, CEO, MediPharm Labs commented, "MediPharm now has the margins, Opex and Adjusted EBITDA results all trending in the right direction.
  • We are proud of the work completed in 2023 and excited about the future of MediPharm Labs."

Opus Wellness: Pioneering a New Era of Boutique Indoor THCa Flower

Retrieved on: 
Tuesday, March 26, 2024
Opus, SAN, Vibration, THC, Family, Heat, THCA, Pharmaceutical industry

The founder's dedication to the mastery of cultivation techniques honed in California since 2011 showcases an unwavering passion for top-tier organic flower.

Key Points: 
  • The founder's dedication to the mastery of cultivation techniques honed in California since 2011 showcases an unwavering passion for top-tier organic flower.
  • Our boutique indoor thca flower is a testament to our commitment to quality, sustainability, and the enduring legacy of the benefits of organic plant medicine."
  • Opus Wellness complies with the 2018 Farm Bill and ensures its THCa flower is 100% legal and safe.
  • With swift delivery, discreet packaging, and no medical card requirement, the highest-quality THCa flower is now more accessible than ever.

Mike Tyson Takes Over New York with TYSON 2.0 Edibles in Partnership with Hudson Cannabis

Retrieved on: 
Tuesday, March 26, 2024
Taste, Empire State, Gummy candy, Partnership, Housing Works, Cannabis, CBN, Stage One, TYSON, Safety, THC, Drug

NEW YORK, March 26, 2024 /PRNewswire/ -- The world-renowned boxing champion Mike Tyson and the global brand powerhouse, CarmaHold Co., announced the arrival of the highly anticipated TYSON 2.0 Mike Bites and Night Bites gummies to New York. In collaboration with leading cultivator Hudson Cannabis, these highly acclaimed edibles are set to revolutionize the Empire State's legal cannabis market with their quality and innovation.

Key Points: 
  • NEW YORK, March 26, 2024 /PRNewswire/ -- The world-renowned boxing champion Mike Tyson and the global brand powerhouse, CarmaHold Co. , announced the arrival of the highly anticipated TYSON 2.0 Mike Bites and Night Bites gummies to New York.
  • In collaboration with leading cultivator Hudson Cannabis , these highly acclaimed edibles are set to revolutionize the Empire State's legal cannabis market with their quality and innovation.
  • "I'm proud to deliver to New York the pinnacle of cannabis experiences through TYSON 2.0's Mike Bites and Night Bite Gummies," said Mike Tyson, co-founder and chief brand officer of TYSON 2.0.
  • Adam Wilks, co-founder and CEO of CarmaHold Co. said, "Partnering with Hudson Cannabis to launch TYSON 2.0 Mike Bites and Night Bite Gummies alongside Mike Tyson is an exciting milestone for CarmaHold Co.

Travelling for Easter? The Canada Border Services Agency gives tips for a smooth trip

Retrieved on: 
Friday, March 22, 2024
Firearm, Narcotic, Friends, Canadian Food Inspection Agency, Letter, Oil, Poultry, Travel, BIS, CBSA, Child, Bird, Tobacco, Food, Health Canada, Cannabis, Holiday, Atmosphere, Water, Arrest, Safety, THC, Family, AIRS, Movement, Canada Border Services Agency, Cannabidiol, Drug

OTTAWA, ON, March 22, 2024 /CNW/ - The Canada Border Services Agency (CBSA) reminds travellers of what to expect when crossing the border over the Easter long weekend.

Key Points: 
  • OTTAWA, ON, March 22, 2024 /CNW/ - The Canada Border Services Agency (CBSA) reminds travellers of what to expect when crossing the border over the Easter long weekend.
  • Here are some tips to help you plan for your trip:
    Plan ahead, expect delays and check border wait times .
  • Border services officers are always watching for missing children , and in the absence of the letter, officers may ask additional questions.
  • You may also contact Border Information Service (BIS) line toll-free within Canada at 1-800-461-9999 for more information

C3 Industries Launches Cannabis-Infused "Galactic Cannabis Gummies" in Massachusetts, Elevating Consumers' Experience to New Heights

Retrieved on: 
Thursday, March 21, 2024
ANN, High, Gummy candy, Relaxation, High Profile, C3, Euphoria, THC, Watermelon, Commonwealth, Drug

ANN ARBOR, Mich., March 21, 2024 /PRNewswire/ -- C3 Industries ("C3" or "the Company,") a leading multi-state cannabis company dedicated to crafting premium cannabis experiences for consumers, announced the launch of its fast-acting cannabis-infused gummies by Galactic Cannabis in the Massachusetts market.

Key Points: 
  • ANN ARBOR, Mich., March 21, 2024 /PRNewswire/ -- C3 Industries ("C3" or "the Company,") a leading multi-state cannabis company dedicated to crafting premium cannabis experiences for consumers, announced the launch of its fast-acting cannabis-infused gummies by Galactic Cannabis in the Massachusetts market.
  • Building upon the success of the Company's previous cannabis product rollouts, including flower, pre-rolls, vapes and concentrates, C3 Industries' Galactic Cannabis gummies offer consumers a delightful and convenient way to embark on a cosmic journey.
  • C3 Industries VP of Marketing, Scott Franco said, "We're excited to offer our new edibles line to the consumers of Massachusetts.
  • For the Massachusetts market, the launch of Galactic Cannabis gummies signifies more than just the introduction of another cannabis product.

CBD Oracle Lab Study Finds "Hemp Gummies" Sold on Amazon with Huge Doses of Delta-8 THC

Retrieved on: 
Wednesday, March 20, 2024
Future, CBD, EBay, Walmart, THC, Policy, Oracle, Doctor of Philosophy, Online shopping

TUSTIN, Calif., March 20, 2024 /PRNewswire/ -- A lab analysis commissioned by CBD Oracle, a cannabis consumer research company, has identified products available on Amazon containing huge quantities of delta-8 THC, which is banned in many states. Despite this, a recent survey revealed that the intoxicating cannabinoid is still popular with teens.

Key Points: 
  • TUSTIN, Calif., March 20, 2024 /PRNewswire/ -- A lab analysis commissioned by CBD Oracle , a cannabis consumer research company, has identified products available on Amazon containing huge quantities of delta-8 THC, which is banned in many states.
  • CBD Oracle purchased 56 hemp products from popular brands on Amazon, sending a selection of gummies, tinctures, topical creams and mints to InfiniteCAL for analysis.
  • Amazon policy prohibits CBD and THC, but brands advertise large doses of unnamed "hemp" ingredients while listing benefits associated with CBD, such as promoting "calm" and "restful nights."
  • They might not contain an ingredient banned by Amazon, but the lab results reveal an even bigger scam: they are just overpriced gummy bears.

Curaleaf to Acquire Northern Green Canada to Bolster European Flower Supply

Retrieved on: 
Tuesday, March 19, 2024
Certification, Establishment, Acquisition, NGC, GMP, Cannabis, TSX, GACP, THC, Drug

NEW YORK, March 19, 2024 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced it has signed a deal to acquire Northern Green Canada ("NGC"), a vertically integrated Canadian licensed cannabis producer focused primarily on expanding in the international market through its EU-GMP certification. NGC also partners with Canadian GACP cultivators to produce and distribute finished cannabis products to both the domestic and global markets.

Key Points: 
  • NGC also partners with Canadian GACP cultivators to produce and distribute finished cannabis products to both the domestic and global markets.
  • By integrating NGC, Curaleaf can significantly increase its European margins while extending its global footprint across three continents: North America, Europe, and Australasia (Australia/New Zealand).
  • It allows Curaleaf to safeguard our position in Europe, enhancing our supply chain while increasing our margins.
  • Lisa McCormack, President and CEO of Northern Green Canada, said, "The NGC team is excited to become a part of the Curaleaf family.

Curaleaf to Acquire Northern Green Canada to Bolster European Flower Supply

Retrieved on: 
Tuesday, March 19, 2024
Certification, Establishment, Acquisition, NGC, GMP, Cannabis, TSX, GACP, THC, Drug

NEW YORK, March 19, 2024 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced it has signed a deal to acquire Northern Green Canada ("NGC"), a vertically integrated Canadian licensed cannabis producer focused primarily on expanding in the international market through its EU-GMP certification. NGC also partners with Canadian GACP cultivators to produce and distribute finished cannabis products to both the domestic and global markets.

Key Points: 
  • NGC also partners with Canadian GACP cultivators to produce and distribute finished cannabis products to both the domestic and global markets.
  • By integrating NGC, Curaleaf can significantly increase its European margins while extending its global footprint across three continents: North America, Europe, and Australasia (Australia/New Zealand).
  • It allows Curaleaf to safeguard our position in Europe, enhancing our supply chain while increasing our margins.
  • Lisa McCormack, President and CEO of Northern Green Canada, said, "The NGC team is excited to become a part of the Curaleaf family.

Real Isolates and Sanctuary Medicinals Announce Launch of Smokenol™-Infused Product Lines

Retrieved on: 
Tuesday, March 12, 2024
Temperature, Cannabinoid, Science, Partnership, Patient, Research, Smoke, Smoking, Medicinals, THC, Sanctuary, Medicinal plants

WOBURN, Mass., March 12, 2024 /PRNewswire/ -- Sanctuary Medicinals is pleased to announce an exciting new partnership with Real Isolates, utilizing their patented Smokenol™ cannabis smoke extraction process for infusion in select Sanctuary products.

Key Points: 
  • WOBURN, Mass., March 12, 2024 /PRNewswire/ -- Sanctuary Medicinals is pleased to announce an exciting new partnership with Real Isolates, utilizing their patented Smokenol™ cannabis smoke extraction process for infusion in select Sanctuary products.
  • Partnering with Real Isolates is a perfect example of that commitment.
  • Co-Founder of Real Isolates, Andy Westerkamp, explains "Real Isolates and Sanctuary Medicinals prioritize quality of life for patients and consumers.
  • Alex Hildrith, Laboratory Director for Sanctuary adds, "Sanctuary's lab team is very excited to announce our official partnership with Real Isolates.